-
Mashup Score: 0
Key Points. Memory T and B cells are present for long periods with different kinetics.Circulating Tfh cells correlate to the Ab production of B cells.Memory T c
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 2
Background COVID-19 vaccines have been crucial in the pandemic response and understanding changes in vaccines effectiveness is essential to guide vaccine policies. Although the Delta variant is no longer dominant, understanding vaccine effectiveness properties will provide essential knowledge to comprehend the development of the pandemic and estimate potential changes over time. Methods In this…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 3
Allergic reactions to the COVID-19 vaccines have raised concerns, particularly as repeated doses are required. Skin tests with the vaccines excipient were found to be of low value whereas the utility of skin tests with the whole vaccine is yet to be determined.
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0
Objectives To evaluate the safety and immunogenicity of third and fourth BNT162b2 boosters in patients with SLE and rheumatoid arthritis (RA). Methods Patients with SLE and RA aged 18–65 years who completed a series of inactivated, adenoviral vector, or heterogenous adenoviral vector/mRNA vaccines for at least 28 days were enrolled. Immunogenicity assessment was done before and day 15 after each…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Objectives To evaluate the safety and immunogenicity of third and fourth BNT162b2 boosters in patients with SLE and rheumatoid arthritis (RA). Methods Patients with SLE and RA aged 18–65 years who completed a series of inactivated, adenoviral vector, or heterogenous adenoviral vector/mRNA vaccines for at least 28 days were enrolled. Immunogenicity assessment was done before and day 15 after each…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Objectives To evaluate the safety and immunogenicity of third and fourth BNT162b2 boosters in patients with SLE and rheumatoid arthritis (RA). Methods Patients with SLE and RA aged 18–65 years who completed a series of inactivated, adenoviral vector, or heterogenous adenoviral vector/mRNA vaccines for at least 28 days were enrolled. Immunogenicity assessment was done before and day 15 after each…
Source: Lupus Science & MedicineCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age | NEJM - 2 year(s) ago
Original Article from The New England Journal of Medicine — BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Objectives To evaluate long-term kinetics of the BNT162b2 mRNA vaccine-induced immune response in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) and immunocompetent controls. Methods A prospective multicentre study investigated serum anti-SARS-CoV-2 S1/S2 IgG titre at 2–6 weeks (AIIRD n=720, controls n=122) and 6 months (AIIRD n=628, controls n=116) after the second…
Source: Annals of the Rheumatic DiseasesCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1
Investigators studied the rates of noninfectious uveitis (NIU) in people who received the initial doses of the BNT162b2 COVID-19 vaccine and compared them with historic NIU rates.
Categories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0
Researchers compared immune responses following COVID-19 vaccination with the mRNA-1273 vs the BNT162b2 vaccines among patients with rheumatic and musculoskeletal diseases and solid organ transplant recipients.
Source: Infectious Disease AdvisorCategories: Infectious Disease, Latest HeadlinesTweet
#AuthorChoice: Dynamics of memory #Tcells and #Bcells before and after the third #BNT162b2 #SARSCoV2 booster in a Japanese cohort | from Setsuko Mise-Omata at Keio University School of Medicine | #ReadTheJI #immunology #omicron #COVID 👉 https://t.co/dBIER3Ut3A https://t.co/77mzhGyDpl